Today we’re going to compare the two available forms of semaglutide: the once-weekly injection and the once-daily tablet.
Both contain semaglutide, but they differ significantly in how the medication is absorbed, how often it’s taken, the instructions for administration, approved uses, storage requirements, and cost.
We’ll also discuss the technology that makes oral semaglutide possible, why the tablet has specific timing requirements, and which option may be a better fit depending on your health history and lifestyle.
Injection vs. Tablet: Same Medication, Very Different Delivery
Let’s start with the most obvious difference.
The injectable version of semaglutide is given subcutaneously, meaning it’s injected under the skin into the fatty tissue. The medication is then absorbed from the tissue into the bloodstream, bypassing the gastrointestinal tract.
The tablet, on the other hand, has to make it through your stomach and be absorbed into your bloodstream.
And that is actually a huge challenge because semaglutide is a peptide.
Peptides don’t behave like typical small-molecule medications. The digestive system is designed to break down proteins and peptides. So if you simply swallowed injectable semaglutide as a regular tablet, your stomach would break much of the peptide down before enough could actually be absorbed.
That’s where the technology behind oral semaglutide becomes really important.
SNAC Technology
The oral tablet contains semaglutide combined with a specialized absorption enhancer called SNAC (salcaprozate sodium).
And SNAC isn’t simply an ingredient added to the tablet as a filler. It’s an important part of the drug-delivery technology.
The tablet is designed to dissolve in the stomach where the semaglutide is primarily absorbed, rather than relying primarily on absorption in the small intestine.
SNAC creates a temporary, localized increase in pH around the tablet. This is important because the stomach is highly acidic, and that acidic environment can break down peptide medications like semaglutide.
So, in simple terms, SNAC creates a temporary, localized environment around the tablet that protects semaglutide and helps it cross the stomach lining.
* Why Does the Pill Have Such Strict Timing Requirements?
With the injection, you don’t have to worry about food.
You take your injection once a week, and it can be administered at any time of day, with or without food.
The tablet is completely different.
The oral semaglutide tablet is taken once every morning on an empty stomach with no more than four ounces of water.
Then you wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medications.
And there’s an important reason for that timing.
Remember, the tablet is relying on SNAC to create that very specific absorption environment in the stomach. Because of this, food, additional liquids and other oral medications taken too close to the dose can interfere with the amount of semaglutide that gets absorbed.
So this isn’t just a pharmaceutical company making the instructions complicated for no reason.
The timing is part of the technology.
And if you don’t follow the administration instructions, you may not get the intended exposure to the medication or desired weight loss outcome.
What About Dosing?
Moving along, I want to highlight the dosing differences between the injectable and oral semaglutide. The injection is generally a once-weekly medication.
You start at a lower dose and gradually increase it over time, allowing your body to adjust and helping improve tolerability. The current injectable semaglutide starts at 0.25 milligrams once weekly and gradually increases to the maintenance dose of 1.7 milligrams to 2.4 milligram once weekly and, in some cases, the dose can go up to 7.2 mg weekly. More on this later in a future podcast.
The oral tablet is a once-daily medication and is also gradually titrated.
The current oral semaglutide regimen starts at 1.5 milligrams once daily and gradually increases to the maintenance dose of 25 milligrams once daily.
This is important because a lot of people make the mistake thinking that the oral tablets are much stronger than the injectable semaglutide.
The problem is that you can’t compare those milligram numbers directly because the route of administration and bioavailability are completely different.
The FDA labeling estimates oral semaglutide bioavailability (the amount of a medication that actually reaches your bloodstream and is available for your body to use) is only about 1% to 2%, which is one of the reasons the oral formulation requires a much larger milligram dose.
* Does one dosage form work better than the other?
Now this is where things get interesting.
The injectable version of Wegovy has shown significant weight loss in clinical trials. With the traditional 2.4 mg weekly dose, people lost about 15% of their starting body weight on average.
More recently, a study directly compared semaglutide HD (Wegovy HD), the 7.2 mg dose, with the standard 2.4 mg dose over 17 months. On average, those taking Wegovy HD lost about 19% of their starting body weight, compared with about 15% with the 2.4 mg dose. Among those who stayed on treatment for the entire study, average weight loss was approximately 21% with Wegovy HD versus 18% with the 2.4 mg dose.
So, the higher 7.2 mg dose may provide additional weight loss for some people who need more than what they achieve with the standard 2.4 mg dose.
In the OASIS 4 trial, oral semaglutide 25 mg resulted in about 16.6% average weight loss among people who stayed on the medication and followed the treatment plan throughout the study. When researchers looked at the results for everyone who started the trial, including those who stopped taking the medication or otherwise did not continue treatment as planned, the average weight loss was lower, at about 14%. In other words, the 16.6% figure reflects the results among people who remained on treatment, while the 14% figure gives a broader picture of what happened across the entire group that started the study.
So you may hear numbers like 15% to 21% for the injection and approximately 14% for the tablet depending on which analysis and trial you’re discussing.
An important point to note here is that these weren’t head-to-head trials comparing the injection and tablet in the exact same population. So I wouldn’t tell someone that one is definitively “stronger” based solely on those percentages.
Both can produce significant weight loss, and individual results vary.
Approved Uses
Now let’s talk about something that’s extremely important.
Even though both products contain semaglutide, their FDA-approved indications aren’t identical.
The injectable and oral semaglutide is approved for chronic weight management in:
- Adults with obesity.
- Adults who are overweight and have at least one weight-related health condition.
- Adolescents age 12 and older with obesity
So what exactly does “weight-related health condition” mean?
It means a medical condition associated with excess weight that can increase health risks.
Examples can include high blood pressure, abnormal cholesterol or triglycerides, type 2 diabetes, cardiovascular disease, obstructive sleep apnea, or other obesity-related conditions.
So someone doesn’t necessarily have to have obesity to qualify for the adult overweight indication. An adult who is overweight and has an appropriate weight-related medical condition may also meet the indication.
The injectable and oral version also have an important cardiovascular indication.
They’re approved to reduce the risk of major cardiovascular events — including cardiovascular death, nonfatal heart attack and nonfatal stroke — in adults with established cardiovascular disease who also have obesity or are overweight.
Where they’re different is that the injectable semaglutide is also FDA-approved for MASH. While the tablet does not currently have that MASH indication.
So What Exactly Is MASH?
MASH stands for metabolic dysfunction-associated steatohepatitis.
You may have heard the older term NASH, or nonalcoholic steatohepatitis.
MASH is a more advanced form of metabolic dysfunction-associated fatty liver disease.
What happens is that fat accumulates in the liver. In some people, that fat is accompanied by inflammation and liver-cell injury. Over time, the ongoing inflammation can lead to fibrosis, or scar tissue.
Progressive liver fibrosis can eventually lead to cirrhosis, liver failure, liver cancer and the need for liver transplantation. MASH is also strongly associated with metabolic health factors such as obesity, type 2 diabetes, high triglycerides and abnormal cholesterol.
So if someone has diagnosed MASH and significant fibrosis, that health history becomes an important part of the conversation about which formulation is appropriate.
Storage and Travel
Another practical difference is storage. The injectable medication has refrigeration requirements, although certain name-brand Wegovy pens can be kept at room temperature for a limited period according to the prescribing information.
The tablets are much simpler from a travel perspective. They are stored at room temperature and should be protected from moisture.
So if you’re someone who travels frequently, especially somewhere where maintaining refrigeration is inconvenient, the tablet may be more convenient.
What About Cost?
Cost is another factor. Depending on insurance coverage, manufacturer programs, pharmacy pricing and where you obtain the medication, the oral formulation may be less expensive for some patients. But there’s no universal rule that the pill will always cost less.
It’s worth comparing your actual out-of-pocket cost for both options.
So Which One Should You Choose?
Now let’s get to the question everyone wants answered.
Injection or tablet?
Well, I would look at several things.
First: How Do You Feel About Injections?
If you’re uncomfortable with needles or simply don’t want to give yourself an injection, the tablet may be an attractive alternative.
If injections don’t bother you, the once-weekly schedule is extremely convenient.
Second: What Does Your Morning Routine Look Like?
This is a big one.
If you wake up, take your medications, drink your coffee and eat breakfast right away, the tablet requires a change in routine.
You need to take it on an empty stomach with no more than four ounces of water and then wait at least 30 minutes before eating, drinking anything besides water or taking other oral medications.
If you’re someone who already has a consistent morning routine and can easily build that 30-minute window into your day, the tablet may work very well.
Third: Do You Tend to Forget Daily Medications?
This is another important consideration.
If you’re the kind of person who occasionally forgets to take a daily medication, a once-weekly injection may actually be easier.
You only have to remember one dose each week rather than remembering a tablet every morning — and the tablet has specific administration requirements that need to be followed correctly.
On the other hand, if you are very consistent with daily medications and don’t mind the morning routine, the tablet may be a great fit.
Fourth: What’s Your Health History?
If you have obesity or are overweight with a weight-related health condition, both formulations may be options depending on your specific circumstances and prescribing considerations.
But if you have MASH with moderate-to-advanced fibrosis, the injectable formulation has a specific FDA-approved indication that the tablet does not.
That’s something that should absolutely be discussed with your healthcare provider.
Fifth: Do You Travel Frequently?
If refrigeration is a concern, the tablet may offer more convenience.
You don’t have to worry about carrying an injectable medication and managing its temperature requirements in the same way.
Leave a Reply